• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Could This Be Pfizer's Next Blockbuster Vaccine?

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 10, 2021 at 11:02: AM
via
  • Pfizer announced that it was starting its phase 3 clinical trial for its respiratory syncytial virus vaccine candidate, known as RSVpreF.
  • If phase 3 clinical results come close to replicating phase 2 results, as expected, Pfizer could have yet another blockbuster vaccine under its belt.
  • Although Pfizer is up 27% year to date, it still trades at an attractive valuation to accompany its great portfolio of products.

article source
 




Top Bottom
Back
Quote